Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

Clinical trial NCT00228982 · COMPLETED

Trial details

NCT number: NCT00228982
Sponsor: Basilea Pharmaceutica
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Skin Diseases, Infectious Skin Diseases, Bacterial Staphylococcal Skin Infections

Start date: 2004-10-01
Primary completion: 2005-12-01
Enrollment: 784

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.